SOLOIST Archives - Cardiac Vascular News

Tag: SOLOIST

Lexicon Pharmaceuticals Provides Regulatory Update on Sotagliflozin in Heart Failure

Coronary/Structural Heart January 14, 2021 by Ken Dropiewski 0 comments

THE WOODLANDS, Texas, Jan. 14, 2021 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that it has received U.S. Food and Drug Administration (FDA) regulatory feedback that the results of its SOLOIST and SCORED Phase 3 clinical studies can support […]

Continue Reading →

Results From SOLOIST and SCORED Outcomes Studies Presented at Late-Breaking Science Session of American Heart Association Scientific Sessions and Published in The New England Journal of Medicine

Coronary/Structural Heart November 17, 2020 by Ken Dropiewski 0 comments

Sotagliflozin Significantly Reduced Total Cardiovascular Deaths, Heart Failure Hospitalization and Urgent Visits, Achieving Primary Endpoint in Both Studies THE WOODLANDS, Texas, Nov. 16, 2020 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced that both the SOLOIST and SCORED Phase 3 […]

Continue Reading →

Tag: SOLOIST

Lexicon Pharmaceuticals Provides Regulatory Update on Sotagliflozin in Heart Failure

Results From SOLOIST and SCORED Outcomes Studies Presented at Late-Breaking Science Session of American Heart Association Scientific Sessions and Published in The New England Journal of Medicine

Recent

Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer

TriSalus Life Sciences® Announces Publication of Pre-Clinical Data Demonstrating Improved Delivery of Embospheres® to Liver Tumors using Pressure-Enabled Drug Delivery™ (PEDD™) via the TriNav® Infusion System

Vensana Capital Closes $425 Million Fund III to Back Breakthrough Medical Technology Companies

Popular

Subscribe to Blog via Email